On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week with the smallest of declines. The benchmark index edged slightly lower to 9,081.4 points.
Will the market be able to bounce back from this on Monday? Here are five things to watch:
Image source: Getty Images
ASX 200 expected to rise
The Australian share market looks set for a decent start to the week following a good finish on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 16 points or 0.2% higher. In the United States, the Dow Jones was up 0.45%, the S&P 500 rose 0.7%, and the Nasdaq stormed 0.9% higher. However, the announcement of US tariffs over the weekend could add some volatility to today’s session.
Oil prices edge higher
It could be a positive start to the week for ASX 200 energy shares such as Santos Ltd (ASX: STO) and Woodside Energy Group Ltd (ASX: WDS) after oil prices edged higher on Friday night. According to Bloomberg, the WTI crude oil price was up 0.1% to US$66.48 a barrel and the Brent crude oil price was up 0.15% to US$71.76 a barrel. Oil prices have been rising after the US weighed up military strikes on Iran.
Half-year results
A number of ASX 200 shares will be on watch today when they release their half-year results. Among them are NIB Holdings Limited (ASX: NHF), Perpetual Ltd (ASX: PPT), and Reece Ltd (ASX: REH). With respect to the latter, Morgans expects the plumbing parts company to report a 22.9% decline in net profit to $139.5 million. It said: “Management noted that the macroeconomic environment remains challenging across ANZ and the US and expects activity in both regions to stay subdued in the near term.”
Gold price jumps
ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) could have a good start to the week after the gold price jumped on Friday night. According to CNBC, the gold futures price was up 1.7% to US$5,080.9 an ounce. This was driven by the release of soft US economic data which supported interest rate cut hopes.
Buy Telix shares
Bell Potter thinks investors should buy Telix Pharmaceuticals Ltd (ASX: TLX) shares following the release of its half-year results. It has retained its buy rating with a trimmed price target of $19.00. It said: “FY25 was a challenging period by virtue to the two CRLs from the FDA and a stream of negative news flow – most recently the sudden resignation of the Chairperson. Nevertheless, the clinical programs are ongoing, and the company is well funded to continue these.”